Karl Landsteiner (1868–1943)
Austrian-born American pathologist and immunologist whose discoveries founded modern transfusion medicine and immunohematology.
Early Life and Education
Karl Landsteiner was born on June 14, 1868, in Vienna, Austria-Hungary. He studied medicine at the University of Vienna, receiving his M.D. in 1891. After graduation, he pursued advanced studies in chemistry in Europe before returning to Vienna to train in pathology, notably under Anton Weichselbaum.
Career
Landsteiner worked as a pathologist in Vienna, where he conducted much of his early serological research. In 1919 he moved to The Hague, Netherlands, and in 1923 joined the Rockefeller Institute for Medical Research in New York City, remaining there until his death on June 26, 1943.
Major Contributions
- ABO Blood Group System (1900–1901): Discovered the A, B, and O blood groups and showed that compatibility between donor and recipient determines the safety of transfusions. This work made routine, life-saving blood transfusion possible.
- Rh Factor (1939–1940): With Alexander S. Wiener, identified the Rh blood group factor, a critical advance for preventing transfusion reactions and for understanding and managing hemolytic disease of the newborn.
- Other Blood Group Systems (1920s): With colleagues such as Philip Levine, helped define additional systems, including the MN and P groups, shaping the field of immunohematology.
- Poliomyelitis Research (1908–1909): With Erwin Popper, demonstrated that poliomyelitis is caused by a filterable virus, a seminal finding in virology.
- Donath–Landsteiner Test (1904): Co-identified the biphasic hemolysin responsible for paroxysmal cold hemoglobinuria and developed a diagnostic test that bears his name.
- Antigen–Antibody Specificity (1930s): Through meticulous chemical and serological studies, clarified the principles of antibody specificity and haptens, summarized in his influential monograph “The Specificity of Serological Reactions” (1936).
Awards and Honors
Landsteiner received the 1930 Nobel Prize in Physiology or Medicine for the discovery of human blood groups (ABO). He was widely honored by scientific societies worldwide for his transformative impact on medicine.
Legacy
Landsteiner’s work established the scientific basis for safe blood transfusion, blood typing, and crossmatching, and it underpins modern transfusion services, organ transplantation compatibility testing, and prenatal care. His rigorous approach to serology and immunochemistry helped define immunology as a quantitative experimental science.